Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Atridia Pty Ltd.
Scientific Title
A Phase I, Open-Label, Multicenter, Non-Randomized, Dose-Escalation Study to Evaluate the Safety and Tolerability of HTI-1090 in Patients With Advanced Solid Tumors